FUBP1_HUMAN - dbPTM
FUBP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID FUBP1_HUMAN
UniProt AC Q96AE4
Protein Name Far upstream element-binding protein 1
Gene Name FUBP1
Organism Homo sapiens (Human).
Sequence Length 644
Subcellular Localization Nucleus .
Protein Description Regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter. May act both as activator and repressor of transcription..
Protein Sequence MADYSTVPPPSSGSAGGGGGGGGGGGVNDAFKDALQRARQIAAKIGGDAGTSLNSNDYGYGGQKRPLEDGDQPDAKKVAPQNDSFGTQLPPMHQQQSRSVMTEEYKVPDGMVGFIIGRGGEQISRIQQESGCKIQIAPDSGGLPERSCMLTGTPESVQSAKRLLDQIVEKGRPAPGFHHGDGPGNAVQEIMIPASKAGLVIGKGGETIKQLQERAGVKMVMIQDGPQNTGADKPLRITGDPYKVQQAKEMVLELIRDQGGFREVRNEYGSRIGGNEGIDVPIPRFAVGIVIGRNGEMIKKIQNDAGVRIQFKPDDGTTPERIAQITGPPDRCQHAAEIITDLLRSVQAGNPGGPGPGGRGRGRGQGNWNMGPPGGLQEFNFIVPTGKTGLIIGKGGETIKSISQQSGARIELQRNPPPNADPNMKLFTIRGTPQQIDYARQLIEEKIGGPVNPLGPPVPHGPHGVPGPHGPPGPPGPGTPMGPYNPAPYNPGPPGPAPHGPPAPYAPQGWGNAYPHWQQQAPPDPAKAGTDPNSAAWAAYYAHYYQQQAQPPPAAPAGAPTTTQTNGQGDQQNPAPAGQVDYTKAWEEYYKKMGQAVPAPTGAPPGGQPDYSAAWAEYYRQQAAYYAQTSPQGMPQHPPAPQGQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADYSTVPP
------CCCCCCCCC
25.1719413330
4Phosphorylation----MADYSTVPPPS
----CCCCCCCCCCC
9.1918491316
5Phosphorylation---MADYSTVPPPSS
---CCCCCCCCCCCC
24.3927251275
6Phosphorylation--MADYSTVPPPSSG
--CCCCCCCCCCCCC
30.7027251275
11PhosphorylationYSTVPPPSSGSAGGG
CCCCCCCCCCCCCCC
53.7825159151
12PhosphorylationSTVPPPSSGSAGGGG
CCCCCCCCCCCCCCC
42.4125159151
14PhosphorylationVPPPSSGSAGGGGGG
CCCCCCCCCCCCCCC
26.2025159151
32UbiquitinationGGVNDAFKDALQRAR
CHHHHHHHHHHHHHH
43.76-
44AcetylationRARQIAAKIGGDAGT
HHHHHHHHHCCCCCC
32.6323954790
44UbiquitinationRARQIAAKIGGDAGT
HHHHHHHHHCCCCCC
32.6321906983
44 (in isoform 1)Ubiquitination-32.6321890473
44 (in isoform 2)Ubiquitination-32.6321890473
51PhosphorylationKIGGDAGTSLNSNDY
HHCCCCCCCCCCCCC
31.5921945579
52PhosphorylationIGGDAGTSLNSNDYG
HCCCCCCCCCCCCCC
25.3321945579
55PhosphorylationDAGTSLNSNDYGYGG
CCCCCCCCCCCCCCC
36.0521945579
58PhosphorylationTSLNSNDYGYGGQKR
CCCCCCCCCCCCCCC
19.2521945579
60PhosphorylationLNSNDYGYGGQKRPL
CCCCCCCCCCCCCCC
16.3221945579
64AcetylationDYGYGGQKRPLEDGD
CCCCCCCCCCCCCCC
60.2926051181
64UbiquitinationDYGYGGQKRPLEDGD
CCCCCCCCCCCCCCC
60.2921906983
64 (in isoform 1)Ubiquitination-60.2921890473
64 (in isoform 2)Ubiquitination-60.2921890473
76AcetylationDGDQPDAKKVAPQND
CCCCCCHHHCCCCCC
55.9825953088
76UbiquitinationDGDQPDAKKVAPQND
CCCCCCHHHCCCCCC
55.9821906983
76 (in isoform 1)Ubiquitination-55.9821890473
76 (in isoform 2)Ubiquitination-55.9821890473
77AcetylationGDQPDAKKVAPQNDS
CCCCCHHHCCCCCCC
45.407378677
77UbiquitinationGDQPDAKKVAPQNDS
CCCCCHHHCCCCCCC
45.40-
84PhosphorylationKVAPQNDSFGTQLPP
HCCCCCCCCCCCCCC
32.8820068231
84 (in isoform 2)Phosphorylation-32.8828674419
87PhosphorylationPQNDSFGTQLPPMHQ
CCCCCCCCCCCCHHH
25.5620068231
87 (in isoform 2)Phosphorylation-25.5620068231
98 (in isoform 2)Phosphorylation-29.0021857030
99PhosphorylationMHQQQSRSVMTEEYK
HHHHHCCCCCCCEEC
22.8423911959
102PhosphorylationQQSRSVMTEEYKVPD
HHCCCCCCCEECCCC
24.4128450419
105PhosphorylationRSVMTEEYKVPDGMV
CCCCCCEECCCCCCE
15.8521406692
118MethylationMVGFIIGRGGEQISR
CEEEEECCCCHHHHH
39.26-
133AcetylationIQQESGCKIQIAPDS
HHHHHCCEEEECCCC
40.9725953088
133UbiquitinationIQQESGCKIQIAPDS
HHHHHCCEEEECCCC
40.97-
140PhosphorylationKIQIAPDSGGLPERS
EEEECCCCCCCCCCC
33.4330266825
147PhosphorylationSGGLPERSCMLTGTP
CCCCCCCCEECCCCH
11.3923403867
148GlutathionylationGGLPERSCMLTGTPE
CCCCCCCEECCCCHH
3.0322555962
148S-nitrosylationGGLPERSCMLTGTPE
CCCCCCCEECCCCHH
3.0322126794
149SulfoxidationGLPERSCMLTGTPES
CCCCCCEECCCCHHH
3.8621406390
151PhosphorylationPERSCMLTGTPESVQ
CCCCEECCCCHHHHH
16.4830266825
153PhosphorylationRSCMLTGTPESVQSA
CCEECCCCHHHHHHH
20.7422167270
156PhosphorylationMLTGTPESVQSAKRL
ECCCCHHHHHHHHHH
27.0230266825
159PhosphorylationGTPESVQSAKRLLDQ
CCHHHHHHHHHHHHH
33.3323927012
161AcetylationPESVQSAKRLLDQIV
HHHHHHHHHHHHHHH
49.1525953088
161UbiquitinationPESVQSAKRLLDQIV
HHHHHHHHHHHHHHH
49.15-
170AcetylationLLDQIVEKGRPAPGF
HHHHHHHCCCCCCCC
49.6925953088
196AcetylationEIMIPASKAGLVIGK
EEEEEHHHCCEEECC
48.8825953088
202 (in isoform 2)Ubiquitination-18.3121890473
203UbiquitinationKAGLVIGKGGETIKQ
HCCEEECCCCHHHHH
53.2521906983
203 (in isoform 1)Ubiquitination-53.2521890473
207PhosphorylationVIGKGGETIKQLQER
EECCCCHHHHHHHHH
36.4322817900
208 (in isoform 2)Ubiquitination-2.0221890473
209UbiquitinationGKGGETIKQLQERAG
CCCCHHHHHHHHHHC
52.99-
209 (in isoform 1)Ubiquitination-52.9921890473
218AcetylationLQERAGVKMVMIQDG
HHHHHCCCEEEEECC
25.5125953088
218UbiquitinationLQERAGVKMVMIQDG
HHHHHCCCEEEEECC
25.51-
219SulfoxidationQERAGVKMVMIQDGP
HHHHCCCEEEEECCC
1.9928183972
221SulfoxidationRAGVKMVMIQDGPQN
HHCCCEEEEECCCCC
1.7228183972
229PhosphorylationIQDGPQNTGADKPLR
EECCCCCCCCCCCCE
28.6220068231
233AcetylationPQNTGADKPLRITGD
CCCCCCCCCCEECCC
45.4726051181
242PhosphorylationLRITGDPYKVQQAKE
CEECCCCHHHHHHHH
28.6528152594
243AcetylationRITGDPYKVQQAKEM
EECCCCHHHHHHHHH
38.6723749302
243MalonylationRITGDPYKVQQAKEM
EECCCCHHHHHHHHH
38.6726320211
243UbiquitinationRITGDPYKVQQAKEM
EECCCCHHHHHHHHH
38.67-
250SulfoxidationKVQQAKEMVLELIRD
HHHHHHHHHHHHHHH
4.0328183972
268PhosphorylationFREVRNEYGSRIGGN
HHHHHHHHHCCCCCC
24.7730576142
270PhosphorylationEVRNEYGSRIGGNEG
HHHHHHHCCCCCCCC
21.5921712546
300UbiquitinationRNGEMIKKIQNDAGV
CCHHHHHHHCCCCCC
38.30-
308MethylationIQNDAGVRIQFKPDD
HCCCCCCCEEECCCC
18.97-
311 (in isoform 2)Ubiquitination-13.2721890473
312SumoylationAGVRIQFKPDDGTTP
CCCCEEECCCCCCCH
31.03-
312AcetylationAGVRIQFKPDDGTTP
CCCCEEECCCCCCCH
31.0323954790
312MalonylationAGVRIQFKPDDGTTP
CCCCEEECCCCCCCH
31.0326320211
312SumoylationAGVRIQFKPDDGTTP
CCCCEEECCCCCCCH
31.03-
312UbiquitinationAGVRIQFKPDDGTTP
CCCCEEECCCCCCCH
31.03-
312 (in isoform 1)Ubiquitination-31.0321890473
317PhosphorylationQFKPDDGTTPERIAQ
EECCCCCCCHHHHHH
46.2929214152
318PhosphorylationFKPDDGTTPERIAQI
ECCCCCCCHHHHHHH
28.7828674419
321MethylationDDGTTPERIAQITGP
CCCCCHHHHHHHHCC
30.65-
331MethylationQITGPPDRCQHAAEI
HHHCCCHHHHHHHHH
27.98-
359DimethylationGGPGPGGRGRGRGQG
CCCCCCCCCCCCCCC
37.23-
359MethylationGGPGPGGRGRGRGQG
CCCCCCCCCCCCCCC
37.2324129315
361DimethylationPGPGGRGRGRGQGNW
CCCCCCCCCCCCCCC
30.21-
361MethylationPGPGGRGRGRGQGNW
CCCCCCCCCCCCCCC
30.2124129315
363DimethylationPGGRGRGRGQGNWNM
CCCCCCCCCCCCCCC
32.66-
363MethylationPGGRGRGRGQGNWNM
CCCCCCCCCCCCCCC
32.6624129315
394AcetylationKTGLIIGKGGETIKS
CCEEEECCCCHHHHH
54.0225953088
394MalonylationKTGLIIGKGGETIKS
CCEEEECCCCHHHHH
54.0226320211
394SuccinylationKTGLIIGKGGETIKS
CCEEEECCCCHHHHH
54.0223954790
394UbiquitinationKTGLIIGKGGETIKS
CCEEEECCCCHHHHH
54.02-
398PhosphorylationIIGKGGETIKSISQQ
EECCCCHHHHHHHHH
36.66-
399 (in isoform 2)Ubiquitination-2.6121890473
400AcetylationGKGGETIKSISQQSG
CCCCHHHHHHHHHCC
49.5123236377
400UbiquitinationGKGGETIKSISQQSG
CCCCHHHHHHHHHCC
49.5121906983
400 (in isoform 1)Ubiquitination-49.5121890473
424 (in isoform 2)Ubiquitination-4.9321890473
425AcetylationPNADPNMKLFTIRGT
CCCCCCCEEEEECCC
47.2723236377
425UbiquitinationPNADPNMKLFTIRGT
CCCCCCCEEEEECCC
47.272189047
425 (in isoform 1)Ubiquitination-47.2721890473
428PhosphorylationDPNMKLFTIRGTPQQ
CCCCEEEEECCCHHH
21.8729214152
430MethylationNMKLFTIRGTPQQID
CCEEEEECCCHHHHH
39.62-
432PhosphorylationKLFTIRGTPQQIDYA
EEEEECCCHHHHHHH
14.2125159151
438NitrationGTPQQIDYARQLIEE
CCHHHHHHHHHHHHH
12.81-
438PhosphorylationGTPQQIDYARQLIEE
CCHHHHHHHHHHHHH
12.8128152594
446UbiquitinationARQLIEEKIGGPVNP
HHHHHHHHHCCCCCC
33.58-
589PhosphorylationYTKAWEEYYKKMGQA
HHHHHHHHHHHHCCC
14.7428152594
590PhosphorylationTKAWEEYYKKMGQAV
HHHHHHHHHHHCCCC
13.8628152594
591AcetylationKAWEEYYKKMGQAVP
HHHHHHHHHHCCCCC
35.0723749302
591SuccinylationKAWEEYYKKMGQAVP
HHHHHHHHHHCCCCC
35.0723954790
592UbiquitinationAWEEYYKKMGQAVPA
HHHHHHHHHCCCCCC
31.94-
601O-linked_GlycosylationGQAVPAPTGAPPGGQ
CCCCCCCCCCCCCCC
48.3532119511
601PhosphorylationGQAVPAPTGAPPGGQ
CCCCCCCCCCCCCCC
48.3521945579
611PhosphorylationPPGGQPDYSAAWAEY
CCCCCCCCHHHHHHH
13.5921945579
612PhosphorylationPGGQPDYSAAWAEYY
CCCCCCCHHHHHHHH
20.9121945579
618PhosphorylationYSAAWAEYYRQQAAY
CHHHHHHHHHHHHHH
9.01-
619PhosphorylationSAAWAEYYRQQAAYY
HHHHHHHHHHHHHHH
8.08-
625PhosphorylationYYRQQAAYYAQTSPQ
HHHHHHHHHHCCCCC
11.4421945579
626PhosphorylationYRQQAAYYAQTSPQG
HHHHHHHHHCCCCCC
6.3621945579
629PhosphorylationQAAYYAQTSPQGMPQ
HHHHHHCCCCCCCCC
33.9126846344
630PhosphorylationAAYYAQTSPQGMPQH
HHHHHCCCCCCCCCC
11.8026846344

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
58YPhosphorylationKinaseSRCP12931
PSP
268YPhosphorylationKinaseSRCP12931
PSP
625YPhosphorylationKinaseSRCP12931
PSP
-KUbiquitinationE3 ubiquitin ligasePRKNO60260
PMID:16672220

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of FUBP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of FUBP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CELF1_HUMANCELF1physical
16169070
DPYL1_HUMANCRMP1physical
16169070
CHD3_HUMANCHD3physical
16169070
VIME_HUMANVIMphysical
16169070
TLE1_HUMANTLE1physical
16169070
SMN_HUMANSMN1physical
10734235
CCNH_HUMANCCNHphysical
11239393
TF2H1_HUMANGTF2H1physical
11239393
UBP22_HUMANUSP22physical
21779003
RM32_HUMANMRPL32physical
22939629
RM41_HUMANMRPL41physical
22939629
KPYM_HUMANPKMphysical
22939629
RM38_HUMANMRPL38physical
22939629
RM02_HUMANMRPL2physical
22939629
RM46_HUMANMRPL46physical
22939629
ITA5_HUMANITGA5physical
22939629
RS15_HUMANRPS15physical
22939629
SRSF3_HUMANSRSF3physical
22939629
PCBP1_HUMANPCBP1physical
22939629
CERS2_HUMANCERS2physical
22939629
RM42_HUMANMRPL42physical
22939629
PGM1_HUMANPGM1physical
22939629
PDCD6_HUMANPDCD6physical
22939629
ACOC_HUMANACO1physical
22863883
CNN2_HUMANCNN2physical
22863883
DD19A_HUMANDDX19Aphysical
22863883
GRPE1_HUMANGRPEL1physical
22863883
H2B1O_HUMANHIST1H2BOphysical
22863883
LEG1_HUMANLGALS1physical
22863883
PLD3_HUMANPLD3physical
22863883
PPP5_HUMANPPP5Cphysical
22863883
ANX11_HUMANANXA11physical
26344197
ANXA2_HUMANANXA2physical
26344197
CCD58_HUMANCCDC58physical
26344197
CHRD1_HUMANCHORDC1physical
26344197
DUT_HUMANDUTphysical
26344197
FUBP3_HUMANFUBP3physical
26344197
NDUS4_HUMANNDUFS4physical
26344197
NDKA_HUMANNME1physical
26344197
PCBP1_HUMANPCBP1physical
26344197
PCBP2_HUMANPCBP2physical
26344197
PPIC_HUMANPPICphysical
26344197
PRDX2_HUMANPRDX2physical
26344197
PRDX5_HUMANPRDX5physical
26344197
RAB1A_HUMANRAB1Aphysical
26344197
SIN3A_HUMANSIN3Aphysical
26344197
SMRC1_HUMANSMARCC1physical
26344197
SMRC2_HUMANSMARCC2physical
26344197
PRKN_HUMANPARK2physical
16672220

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of FUBP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-52; SER-55; THR-153 AND SER-630, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-630, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-52; SER-55; THR-153 AND SER-630, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; THR-153 ANDSER-630, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153 AND SER-630, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-626, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-58, AND MASSSPECTROMETRY.

TOP